ALBRIT™ 200 contains Pirfenidone 200 mg, a proven antifibrotic and anti-inflammatory medication used to treat Idiopathic Pulmonary Fibrosis (IPF). This progressive lung disease leads to scarring of lung tissues, making it harder to breathe. ALBRIT™ 200 helps slow the progression of fibrosis, reduces lung inflammation, and improves breathing capacity.
By targeting fibrotic pathways, ALBRIT™ 200 helps maintain lung function and enhance quality of life for patients with IPF. Regular use reduces disease progression, making it a crucial treatment for long-term lung health.
Indications
ALBRIT™ 200 is primarily prescribed for:
Idiopathic Pulmonary Fibrosis (IPF) – Reduces lung scarring and slows disease progression.
Lung Fibrosis due to Other Causes – May be prescribed for other forms of interstitial lung disease (ILD) under medical supervision.
Improving Lung Function – Helps enhance breathing and reduce respiratory discomfort in fibrotic lung conditions.
Doctors prescribe ALBRIT™ 200 to help manage and slow lung fibrosis effectively.
Dosage & Administration
Recommended Dosage:
- Initial Dose: 200 mg (1 tablet) three times daily with food.
- Titration Phase: The dosage is gradually increased over 14 days to 600 mg/day.
- Maintenance Dose: 600–1800 mg/day in divided doses, as recommended by the physician.
How to Take ALBRIT™ 200:
- Take the tablet with food to reduce the risk of nausea and stomach upset.
- Swallow the tablet whole with water—do not crush or chew.
- Follow the titration schedule prescribed by your doctor for safe dose escalation.
- Maintain regular medical check-ups to monitor lung function and potential side effects.
Important: Never adjust your dosage without medical supervision. Sudden discontinuation can affect treatment efficacy.
Precautions & Warnings
Sun Protection Required: ALBRIT™ 200 increases sun sensitivity, so wear sunscreen (SPF 50+) and protective clothing.
Monitor Liver Function: Regular liver tests are needed to prevent liver toxicity.
Avoid Alcohol & Smoking: These can worsen lung fibrosis and reduce drug effectiveness.
Caution in Kidney Disease: Dose adjustments may be needed for patients with renal impairment.
Pregnancy & Breastfeeding: Consult a doctor before use—safety data in pregnant women is limited.
Drug Interactions: Inform your doctor about all medications, especially antibiotics, NSAIDs, and blood thinners.
Seek immediate medical attention if you experience severe skin reactions, liver toxicity symptoms, or worsening breathing difficulties.
Why Choose ALBRIT™ 200?
Clinically Proven for IPF Treatment: Slows lung fibrosis and improves lung function.
Anti-Inflammatory & Antifibrotic Properties: Reduces lung tissue scarring effectively.
Well-Tolerated with Food: Minimizes gastric discomfort and improves absorption.
Enhanced Quality of Life: Helps maintain better breathing and daily activities.
Convenient Tablet Form: Easy oral administration for long-term treatment.
ALBRIT™ 200 (Pirfenidone 200 mg) is a reliable and effective antifibrotic treatment that slows the progression of Idiopathic Pulmonary Fibrosis (IPF). Its anti-inflammatory properties help reduce lung scarring, improve breathing, and enhance lung function.
For better lung health and long-term IPF management, choose ALBRIT™ 200. Always follow your doctor’s instructions for maximum benefits.
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category www.allengeindia.com/product-category/anti-allergic-anti-cold-cough
You can also contact us www.allengeindia.com/contact-us
